Dr. Samer Sam Eldika, MD

Dr. Eldika practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Dr. Eldika's NPI, 1346267093, was assigned on July 17, 2006. Dr. Eldika graduated from American University of Beirut Faculty of Medicine in 1998. Dr. Eldika holds California license C150038.

Dr. Eldika's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Dr. Eldika's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Dr. Eldika is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Eldika to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eldika practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Eldika's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Eldika is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Eldika's licenses on file in 5 states: California, Ohio, Florida, Indiana and Virginia.

Dmand AI lists acid reflux, colonoscopy, esophagus, stomach, or upper small intestine surgery, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Eldika treats.

CMS data shows 917 Medicare services from Dr. Eldika across 25 procedure codes in 2024, for 453 Medicare patients. Medicare paid $123,043 for them.

CMS counts 453 Medicare patients who saw Dr. Eldika in 2024. The largest group is 65 to 74, with 192 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Eldika's median patient age at 66, with 52% women.

In 2024, Dr. Eldika wrote 199 Medicare Part D claims for 117 patients. 74% of them were for generic drugs. CMS names the drug for 113 of them, across 6 drugs with 11 or more claims each, at $2,624 in total drug cost. In 2023, CMS named 105 claims across 4 drugs.

Dr. Eldika accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eldika as offering telehealth. CMS counts 544 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Eldika, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Eldika in 2024. Dr. Eldika's most frequent co-authors are Monica Makiko Dua, MD, Shai Friedland, MD and Jon Michael Harrison, MD.

Dmand AI links Dr. Eldika to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Pancreatic Cyst and Cysts.

CMS Open Payments shows 95 general payments to Dr. Eldika from 16 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $14,813. It also lists 1 research payment totaling $3,000 in 2021.

Dmand AI lists 1 award for Dr. Eldika, most recently CMS Stage 1 EHR in 2013.

Dr. Eldika graduated from American University of Beirut Faculty of Medicine in 1998.

Dr. Eldika is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.